Diversified Consumer Services
Company Overview of University of Alabama at Birmingham
University of Alabama at Birmingham (UAB) is an educational institution that offers undergraduate and graduate programs in arts, biochemistry, chemistry, engineering, environment, and nursing. The schools of the university include School of Arts & Humanities, School of Business, School of Engineering School of Medicine School of Nursing, and School of Public Health. UAB was founded in 1969 and is based in Birmingham, Alabama. It has endowment assets worth $247.6 millions.
701 20th St S Ab1070
Birmingham, AL 35233-2031
Founded in 1936
Key Executives for University of Alabama at Birmingham
Chief Executive Officer of The University of Alabama-Birmingham Research Foundation
Chief Executive Officer of Health System
Associate Provost for Administration and Finance
Dean of School of Business
Compensation as of Fiscal Year 2014.
University of Alabama at Birmingham Key Developments
Navidea Biopharmaceuticals, Inc. to Collaborate with University of Alabama at Birmingham on Clinical Study Evaluating the RIGS Monoclonal Antibody Targeting Agent
Nov 26 13
Navidea Biopharmaceuticals Inc. announced it will collaborate with investigators at the University of Alabama at Birmingham on a clinical study to evaluate the safety and activity of a radiolabeled, humanized monoclonal antibody (Mab) from its RIGS Monoclonal Antibody Targeting technology. The study will evaluate up to 20 patients with colorectal cancer (CRC) by administering the RIGS tumor-specific radiolabeled, CH2 domain-deleted, anti-TAG-72 Mab-targeting agent and assessing by SPECT/CT imaging for the presence of liver metastasis. The co-principle investigators for the study are Andres Forero, MD, the O'Neal-Sokol Breast Cancer Research Foundation of Alabama Endowed Professorship, Director, Protocol/Data Management Shared Facility, and Co-Leader, Experimental Therapeutics, UAB Comprehensive Cancer Center; Kurt Zinn, DVM, MS, PhD, Director, Advanced Medical Imaging Research, UAB; and Janis P. O'Malley, MD, Director, Division of Molecular Imaging and Therapeutics, and Professor of Radiology, UAB School of Medicine. The study is to be funded in part through the company's Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI), National Institutes of Health (NIH) announced in 2012.
The University of Alabama At Birmingham Selects New chairman for its Departments of Biology and Social Work
Nov 26 13
The University of Alabama at Birmingham has selected new chairman for its departments of biology and social work. UAB announced that Steven Austad has been named chairman of the biology department, while David Pollio has been named chairman of the social work department. Austad comes to UAB from the University of Texas Health Sciences Center at San Antonio. In Texas, he served as a cellular and structural biology professor and interim director of the health science center's Barshop Institute for Longevity and Aging Studies. Starting in January 2014, Austad will serve as the scientific director for the American Federation for Aging Research. Pollio previously served as the Hill Crest Endowed Chair in mental health for the University of Alabama's School of Social Work. He is also a senior scientist the UAB med school's Center of AIDS Research.
University of Alabama At Birmingham Wins $9.62 Million Federal Contract from the U.S. Department of Health and Human Services's National Institutes of Health
Aug 16 13
University of Alabama at Birmingham won a $9,617,172 federal contract from the U.S. Department of Health and Human Services's National Institutes of Health, Bethesda, Md., for one Coordinating Center as part of the Coronary Artery Risk Development in Young Adults Study renewal.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|